Skip to main content
Home Medicines for Malaria Venture

Developing antimalarials to save lives

Main navigation

  • Our work
    • Go back
    • Our work
    • MMV's pipeline of antimalarial drugs
      • Go back
      • MMV's pipeline of antimalarial drugs
      • Annual report 2022
      • Antimalarials for children
      • Antimalarials for pregnant women
      • Antimalarial drug resistance
    • Global health and societal change
      • Go back
      • Global health and societal change
      • Sustainable Development Goals
      • Gender equity
      • African manufacturing
      • Climate change and malaria
    • Research and development
      • Go back
      • Research and development
      • Target Product & Candidate Profiles
      • Frontrunner templates
    • Access to medicines
      • Go back
      • Access to medicines
      • Product registration maps
      • Antimalarial drug toolkits
  • Partnering & opportunities
    • Go back
    • Partnering & opportunities
    • Global partner network
      • Go back
      • Global partner network
      • Endemic country partners
    • Business model
    • Intellectual property rights
    • Opportunities
      • Go back
      • Opportunities
      • Requests for information or proposals
  • Newsroom
  • Malaria
    • Go back
    • Malaria
    • Definitions and symptoms
    • Malaria facts and statistics
    • Lifecycle of the malaria parasite
    • Species of Plasmodium parasites
    • History of antimalarial drugs
    • Malaria guidelines
  • About us
    • Go back
    • About us
    • About us
      • Go back
      • About us
      • Careers
      • FAQs
      • Diversity, Equity & Inclusion
      • Policies
      • Funding & expenditure
      • Donors
    • People & governance
      • Go back
      • People & governance
      • Staff bios
      • Board of Directors
      • North America Inc. Board
      • Access and Product Management Advisory Committee
      • Expert Scientific Advisory Committee
      • Global Safety Board
  • MMVOpen
    • Go back
    • MMVOpen
    • Open compounds
      • Go back
      • Open compounds
      • Call for antimalarial compounds
      • Global health priority box
      • Pandemic Response Box
    • Open dose and PK prediction tool
    • Open source drug discovery programme
      • Go back
      • Open source drug discovery programme
      • Open data repository
    • MMVOpen team
What are you looking for?
Home Call for proposals
Call for proposals

Call for proposals

MMV has a call for proposals in the first quarter of each year. This is announced on our website. You can also keep informed by subscribing to our e-newsletter.

Past calls for proposals (now closed):

  • 5th African Call for proposals
  • 20th Call for proposals (2022)
  • 19th Call for proposals (2021)
  • 18th Call for proposals (2020)
  • 17th Call for proposals (2019)
  • Grand Challenges Africa: call for proposals for drug discovery
  • 16th Call for proposals (2018)
  • 15th Call for proposals (2017)
  • 14th Call for proposals (2016)
  • Endemic-Region Challenge Grants to exploit the Pathogen Box (2016)
  • 13th Call for proposals (2015)
  • Malaria Box Challenge Grants (2014)
  • 12th Call for proposals (2014)
  • 11th Call for proposals (2013)
  • 10th Call for proposals (2012)
  • 9th Call for proposals (2011)

MMV has a call for proposals in the first quarter of each year. This is announced in January on our website. Subscribe to our e-newsletter to keep up with our work and to be informed of the next call for proposals.

Contact us

+41 22 555 03 00

info@mmv.org

Find us

Follow us

Facebook Linkedin Twitter YouTube

Subscribe

Previous newsletters
  • Disclaimer
  • Privacy policy
© MMV 2023
A site by Manta Ray Media